New combo therapy targets Stomach-Lining cancer in early trial
NCT ID NCT07454031
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new drug combination (PX plus nab-paclitaxel) given directly into the abdomen for people with a type of advanced cancer that has spread to the lining of the belly. The main goal is to find a safe dose and check for side effects. About 22 adults with this specific cancer will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL (METASTATIC) CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental shot takes aim at stomach cancer spread
- Heated chemo during surgery: new hope for advanced pancreatic cancer?
- New study aims to predict who benefits from abdominal cancer surgery
- Could a constipation drug help keep colorectal cancer at bay?
- New triple therapy aims to shrink abdominal tumors in colorectal cancer
- Heated vs. sprayed chemo: which works better for belly cancer?